Bracco Diagnostics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
A Pharmacokinetics Study of MultiHance in Pediatric Patients
Phase 1
Completed
- Conditions
- Central Nervous System Pathology
- First Posted Date
- 2006-12-15
- Last Posted Date
- 2008-01-11
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 15
- Registration Number
- NCT00411931
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
- First Posted Date
- 2006-12-06
- Last Posted Date
- 2009-03-27
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 100
- Registration Number
- NCT00408083
- Locations
- 🇮🇹
Bracco Imaging, Milan, Italy
Multihance at 3 Tesla (3T) in Brain Tumors
- First Posted Date
- 2006-11-06
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 46
- Registration Number
- NCT00395863
- Locations
- 🇺🇸
Bracco Diagnostics, Inc., Princeton, New Jersey, United States
Detection of Pulmonary Embolism With CECT
Phase 4
Completed
- Conditions
- Pulmonary Embolism
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2008-01-07
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT00351754
- Locations
- 🇺🇸
Bracco Diagnostics, Inc., Princeton, New Jersey, United States
A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain
Phase 4
Completed
- Conditions
- Brain Pathology
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2008-01-23
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 114
- Registration Number
- NCT00323102
- Locations
- 🇺🇸
Bracco Diagnostics, Inc., Princeton, New Jersey, United States
Safety and Efficacy of MultiHance in Pediatric Patients
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2010-10-22
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 92
- Registration Number
- NCT00323310
- Locations
- 🇺🇸
Bracco Diagnostics, Inc., Princeton, New Jersey, United States
Patients With Renal Impairment Undergoing CT
Phase 4
Completed
- Conditions
- Contrast Induced Nephropathy
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT00292487
- Locations
- 🇺🇸
Bracco Diagnostics, Inc, Princeton, New Jersey, United States
Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
Phase 4
Completed
- Conditions
- Kidney Diseases
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2008-01-07
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 350
- Registration Number
- NCT00289614
- Locations
- 🇺🇸
Bracco Diagnostics, Inc., Princeton, New Jersey, United States
A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
Phase 4
Completed
- Conditions
- CIN
- First Posted Date
- 2006-02-09
- Last Posted Date
- 2006-08-18
- Lead Sponsor
- Bracco Diagnostics, Inc
- Target Recruit Count
- 400
- Registration Number
- NCT00289029
- Locations
- 🇺🇸
Bracco Diagnostics, Inc, Princeton, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath